Brexpiprazole versus placebo or other antidepressive agents for treating depression
2021
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute‐ and long‐term treatment of major depression.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
0
Citations
NaN
KQI